Daxokafusp alfa
Daxokafusp alfa (SAR445877) is an antibody-cytokine fusion protein composed of an Fc-silenced human anti-PD-1 IgG1 conjugated to a mutant IL-15/IL-15 receptor α Sushi domain fusion. Daxokafusp alfa blocks the binding of PD-1 to PD-L1/PD-L2. Daxokafusp alfa activates the STAT5 signaling pathway. Daxokafusp alfa induces IFN-γ production, with minimal IL-6 and TNF-α secretion. Daxokafusp alfa can be used for cancer research.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
|
IL-15 |
STAT5 |
In Vitro
Daxokafusp alfa blocks PD-1/PD-L1 and PD-1/PD-L2 interactions in a dose-dependent manner[2].
Daxokafusp alfa has minimal complement fixation and CDC/ADCC activity, consistent with its silenced Fc region[2].
Daxokafusp alfa weakly binds HEK293 cells expressing IL-2Rβ[2].
Daxokafusp alfa preferentially delivers IL-15-mediated pSTAT5 signaling to PD-1+ M07e cells in mixed co-cultures[2].
Daxokafusp alfa (up to 300 nM; 5 days) stimulates the cytotoxicity of NK cells against K562 target cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c human PD-1/PD-L1 knock-in (GemPharmatech)[2]
-
Dosage:0.5-12 mg/kg (single dose); 6 mg/kg once weekly for 3 weeks
-
Administration:i.v.; single dose or once weekly for 3 weeks
-
Result:Single i.v. doses from 0.5 to 12 mg/kg produced dose-dependent antitumor efficacy.
6 mg/kg once weekly for 3 weeks induced tumor stasis.
2 treated mice achieved complete tumor clearance with no regrowth through 87 days.
94.8% tumor growth inhibition was achieved.
Coadministration with anti-PD-1 reduced tumor growth inhibition to 68.2%.
12 mg/kg showed stronger antitumor efficacy than anti-PD-1 plus IgG-IL-15 mutein.
Target
PD-1&IL-15 Receptor
Application
ELISA, FACS, Functional assay
Product Details
-
Synonyms SAR445877
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Mouse IgG2a kappa
-
Recommend Isotype Controls
Product Properties
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Daxokafusp alfa
- SAR445877
- SAR 445877
- SAR-445877
- PD-1/PD-L1
- Interleukin Related
- STAT
- IFNAR
- PD-1/Programmed death-ligand 1
- IL
- Interferon-α/β receptor
- Interferon-alpha/beta receptor
- CD8+ T cells
- IFN-γ
- IL-15 receptor agonist
- JAK/STAT5 signaling
- PD-1
- PD-L1
- PD-L2
- T-cell exhaustion
- natural killer cells
- solid tumors
- Inhibitor
- inhibitor
- inhibit